Lung Cancer & COVID-19 Webinar.

December 20, 2020

Author: Acteropharma

Regarding the Importance of experience sharing about Lung cancer patients with COVID-19 complications, a multidisciplinary virtual Meeting was held on December 3rd 2020, with the topic of “Lung Cancer & COVID19” with the presence of Dr. Khosravi (Medical Oncologists), Dr. Seifi (Medical Oncologists), Dr. Salimi (Medical Oncologists), Dr. Kiani (Pulmonologist), Dr. Naseri (Radio Oncologist), Dr. Bakhshayesh karam (Radiologist), Dr. Daneshvar (Thoracic Surgeon). Erlotinib ACTe & Pemetrexed ACTe are two ACTERO’s products, which has a certain position in lung cancer treatment.

Last News

EHA 2023 Actero Sponsorship

June 26, 2023

Author:

Acteropharma

Actero Support in Congress 1400

July 24, 2022

Author:

Acteropharma

Actero company’s social respomsibility of patient support in Hematology-Oncology Congress and Radiation Therapy Congress

Best of ASCO 2021

November 16, 2021

Author:

Acteropharma

The aforesaid seminar has been held for the first time in Iran with the hospitality of Isfahan city, with the cooperation of Radiation-Oncologists from all over of the country and Actero Pharma.